Search
for
Sort by
Research 211–240 of 1000+
- Adverse effects of common medications on male fertility
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review
- Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation
- Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase
- Evidence-based approach to cutaneous hyperandrogenism in women
- Hair loss and herbs for treatment
- Male pattern baldness and the risk of prostate cancer
- Binary and ternary inclusion complexes of finasteride in HPβCD and polymers: Preparation and characterization
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Treatment options for alopecia: an update, looking to the future
- Leydig Cell Hyperplasia and Adenomas in Mice Treated with Finasteride, a 5α-Reductase Inhibitor: A Possible Mechanism
- Intermittent Use of Testosterone Inactivating Pharmaceuticals Using Finasteride Prolongs the Time Off Period
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink
- 5α-Reductase inhibitors in androgenetic alopecia
- Role of stem/progenitor cells in reparative disorders
- Post-finasteride syndrome: An emerging clinical problem
- Effects of Short-Term Finasteride on Apoptotic Factors and Androgen Receptors in Prostate Cancer Cells
- Androgen receptor modulators: a review of recent patents and reports (2012-2018)
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Novedades terapéuticas en tricología
- Chapter 17. Selective androgen receptor modulators (SARMs)
- From gene to therapy in spinal and bulbar muscular atrophy: Are we there yet?
- Male Pattern Baldness in Relation to Prostate Cancer–Specific Mortality: A Prospective Analysis in the NHANES I Epidemiologic Follow-up Study
- Discontinuation of Alpha-Blockade after Initial Treatment with Finasteride and Doxazosin for Bladder Outlet Obstruction
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- 5-Alpha-Reductase Inhibitors and Combination Therapy